Home > Resources > Whitepapers > CRISPR Knockouts: Understanding Repair Outcomes

CRISPR Knockouts: Understanding Repair Outcomes

August 23, 2019

One of the primary uses of CRISPR is to knock out genes in order to study their function. Although CRISPR enables this process by producing a double-strand break in the DNA, the subsequent repair of the break is what actually induces a knockout.

Spotlight

Scantibodies Laboratory, Inc

In vitro diagnostic company, specializing in the production of antibodies, controls, blockers including HBR. Clean Rooms, Filling, Finishing, Packaging, Sub-Assembly, Inventory Space, Kit Manufacturing, Lyophilization, Antibody Production and Medical Device Manufacturing

OTHER WHITEPAPERS

Application of Single-Use Technologies(SUT) in Biosimilar Development

whitePaper | December 20, 2022

The current processing paradigm of large manufacturing facilities dedicated to singleproduct production is no longer an effective approach for best manufacturing practices.

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Advancing Diversity in Clinical Development through Cross-Stakeholder Commitment and Action

whitePaper | November 10, 2022

The call for achieving representative diversity in clinical trials and development programs is not new and indeed dates back more than five decades in the United States but has been amplified over the course of the COVID-19

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Bold Goals for U.S. Biotechnology and Biomanufacturing

whitePaper | March 22, 2023

The world is on the cusp of an industrial revolution fueled by biotechnology and biomanufacturing. Emerging biological technologies are and will continue to transform the foundation of our physical world – everything from clothing, to plastics, to fuels, to concrete.

CRISPR Knockouts: Understanding Repair Outcomes

Spotlight

Scantibodies Laboratory, Inc

OTHER WHITEPAPERS

Application of Single-Use Technologies(SUT) in Biosimilar Development

Cell and Gene Therapy Clinical Trials

Advancing Diversity in Clinical Development through Cross-Stakeholder Commitment and Action

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

Synthetic Biology Biotechnology and AgTech

Bold Goals for U.S. Biotechnology and Biomanufacturing

Application of Single-Use Technologies(SUT) in Biosimilar Development

Cell and Gene Therapy Clinical Trials

Advancing Diversity in Clinical Development through Cross-Stakeholder Commitment and Action

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

Synthetic Biology Biotechnology and AgTech

Bold Goals for U.S. Biotechnology and Biomanufacturing

Spotlight

Scantibodies Laboratory, Inc

Events